Similarly, Lo et al., demonstrated that the administrated of anti-FAP CAR T cells reduced extracellular matrix proteins and glycosaminoglycans; with a concurrent decrease in tumor vascular density and growth in preclinical desmoplastic human lung cancer xenografts and syngeneic murine pancreatic cancers [112]. This evidence concerns the gene FAP and neoplasm.